Ophthalmology Glaucoma
metrics 2024
Advancing the Frontiers of Glaucoma Research
Introduction
Ophthalmology Glaucoma is a premier academic journal dedicated to advancing the understanding and management of glaucoma, a leading cause of irreversible blindness worldwide. Published by Elsevier, this journal covers a broad spectrum of topics within the field of ophthalmology, providing a platform for groundbreaking research and clinical insights. With an impressive impact factor that places it in the Q1 category of ophthalmology journals, and a commendable Scopus ranking of 29 out of 137, Ophthalmology Glaucoma is recognized for its rigorous peer-review process and high-quality publications. Since its inception in 2018, the journal has focused on disseminating innovative findings and treatment modalities to enhance patient care and outcomes. Researchers, clinicians, and students are encouraged to explore the Open Access options available, promoting wider accessibility to critical scientific knowledge. By staying at the forefront of ophthalmic research, Ophthalmology Glaucoma plays an essential role in shaping practices and policies that improve eye health globally.
Metrics 2024
Metrics History
Rank 2024
Scopus
IF (Web Of Science)
JCI (Web Of Science)
Quartile History
Similar Journals
Journal of the Korean Ophthalmological Society
Connecting Scholars to Transform Vision ScienceThe Journal of the Korean Ophthalmological Society, with ISSN 0378-6471 and E-ISSN 2092-9374, is a pivotal resource in the field of ophthalmology, published by the esteemed Korean Ophthalmological Society. Based in South Korea, this journal is committed to advancing knowledge in ophthalmology through the dissemination of research that spans both clinical and experimental studies. Despite its current Q4 ranking in the 2023 Ophthalmology category, it serves as a crucial platform for emerging scholars, practitioners, and students seeking to contribute to and learn from the latest developments in eye care. While the journal does not currently offer open access, it is dedicated to fostering scientific dialogue and innovation within the community. With convergence years from 2018 to 2024, the journal's focus on contemporary issues in ophthalmology positions it as a relevant and timely source of information, critical for those engaged in this dynamic field. For further inquiries, the journal can be contacted at their address in Seoul, South Korea: SKY 1004 BLDG 701, 50-1 Jungnim-ro, Jung-gu, 04508.
Journal of Translational Internal Medicine
Advancing Internal Medicine through Innovative ResearchThe Journal of Translational Internal Medicine is a renowned platform dedicated to advancing the field of internal medicine through the dissemination of high-quality research and innovative clinical practices. Published by SCIENDO, this journal boasts a respectable Q2 ranking in the Internal Medicine category and is placed in the 69th percentile among its peers, highlighting its significant contribution to the discipline. With its ISSN 2450-131X and E-ISSN 2224-4018, the journal offers an open-access format, promoting accessibility to vital research findings for professionals and scholars around the globe. Located in Poland, the journal has been a valuable resource since its inception in 2018, and it continues to thrive through 2024 and beyond, supporting the objective of translating research into practice, enhancing patient care, and fostering collaboration among researchers and healthcare providers. This makes it an essential read for anyone invested in improving medical outcomes and understanding the evolving challenges faced in internal medicine.
Prostate Cancer
Empowering discoveries in urology and oncology.Prostate Cancer is a leading peer-reviewed Open Access journal published by HINDAWI LTD, dedicated to advancing the field of urology and oncology through high-quality research and innovative studies. Established in 2011, this journal serves as a vital platform for disseminating findings related to prostate cancer diagnostics, treatment strategies, and patient care, striving to collaborate and connect researchers from around the globe. With an impact factor reflective of its critical input in the scientific community, the journal showcases compelling manuscripts, reviews, and case reports that are accessible to a wide audience given its open access policy. Located in London, England, Prostate Cancer has made significant strides in its category quartiles, achieving Q4 in Cancer Research and Q3 in both Oncology and Urology as of 2023, reflecting its growing relevance and readership. With Scopus rankings indicating its position within the broader medical fields, the journal is a valuable resource for researchers, professionals, and students alike, contributing to the collective effort to improve outcomes in prostate cancer research and treatment.
Journal of Current Ophthalmology
Empowering Care: Transforming Eye Health Through ResearchJournal of Current Ophthalmology is a premier scholarly platform dedicated to advancing the field of ophthalmology, published by Wolters Kluwer Medknow Publications. Established as an Open Access journal since 2015, it aims to provide unrestricted access to high-quality research that fosters knowledge sharing and collaboration among researchers, practitioners, and students in the field. The journal covers a broad spectrum of topics within ophthalmology, from clinical practices to groundbreaking research, contributing significantly to the medical community's understanding of eye health and diseases. With an impact factor reflecting its significance, it ranks in the Q2 category of ophthalmology and stands at #66 out of 137 in Scopus rankings, placing it in the 52nd percentile of its field as of 2023. The Journal of Current Ophthalmology is committed to publishing cutting-edge findings and innovative solutions, establishing itself as an essential resource for all professionals engaged in ocular research and care.
JOURNAL OF CLINICAL PERIODONTOLOGY
Pioneering Innovations in Periodontology Since 1974JOURNAL OF CLINICAL PERIODONTOLOGY, published by Wiley, is a leading academic journal dedicated to advancing the understanding and practice of periodontology. Since its inception in 1974, the journal has carved a niche in the field, achieving a remarkable Q1 ranking in Periodontics and securing a commendable Scopus rank of #2 out of 24 in Dentistry, placing it within the 93rd percentile of its category. With a robust commitment to publishing rigorous research, clinical studies, and comprehensive reviews, the journal provides an essential platform for researchers, dental professionals, and students to disseminate knowledge and keep abreast of the latest advancements in periodontal science. Although the journal is not open access, it remains highly influential in shaping the practices that underpin effective patient care and improving oral health globally. The journal's address in Hoboken, New Jersey, belies its international reach and the diverse contributions it attracts from around the world, ensuring its relevance and prestige in the rapidly evolving landscape of clinical periodontology.
BREAST
Shaping the future of oncology with peer-reviewed excellence.BREAST is a leading peer-reviewed journal dedicated to advancing knowledge and practice in the fields of cancer research, oncology, and surgery, published by Churchill Livingstone. With an impressive impact factor and a prestigious Q1 ranking in multiple categories including Cancer Research, Medicine, and Surgery, the journal consistently delivers high-quality content that informs and inspires researchers, clinicians, and educators. Since its transition to Open Access in 2020, BREAST has significantly expanded its reach, providing immediate and unrestricted access to pivotal studies and findings in breast health and disease management. With a history dating back to 1992 and converging to 2024, the journal serves as an essential resource for the latest developments and innovative approaches in the clinical and biomedical aspects of breast care. Scholars and professionals alike can explore a wealth of research aimed at improving patient outcomes and fostering scientific dialogue in this vital area of healthcare.
Spektrum der Augenheilkunde
Advancing the Vision of OphthalmologyWelcome to Spektrum der Augenheilkunde, a distinguished journal published by SPRINGER WIEN, dedicated to the field of ophthalmology since its inception in 1987. With an ISSN of 0930-4282 and an E-ISSN of 1613-7523, this journal is recognized for its commitment to publishing original research, reviews, and clinical studies that address current and emerging topics in eye health and treatment. Although classified in the Q4 category for ophthalmology as per the latest 2023 rankings, it serves as a valuable platform for researchers, professionals, and students looking to contribute to and expand their knowledge in this vital area of medicine. Based in Austria and accessible through various academic databases, the journal aims to foster communication among professionals and advance the understanding of ocular diseases, innovative therapies, and clinical best practices.
Journal of VitreoRetinal Diseases
Illuminating the path to better retinal health.Journal of VitreoRetinal Diseases is a leading publication in the field of ophthalmology, specifically focusing on the complex landscape of vitreo-retinal conditions. Released by SAGE Publications Inc, this journal plays a crucial role in advancing the understanding and treatment of retinal diseases through high-quality, peer-reviewed research. With an ISSN of 2474-1264 and an E-ISSN of 2474-1272, the journal has gained recognition since its inception in 2017, currently ranking in the Q3 category of ophthalmology based on its Scopus metrics. Positioned within the 31st percentile among its peers, the journal provides a platform for the dissemination of innovative findings and clinical practices. Although it operates under a traditional access model, the significance of its contributions is profound, making it an essential resource for researchers, healthcare professionals, and students dedicated to improving patient outcomes in retinal health.
Seminars in Ophthalmology
Exploring Innovations in OphthalmologySeminars in Ophthalmology is a prestigious journal published by Taylor & Francis Inc, dedicated to advancing knowledge in the field of ophthalmology and related medical areas. Established in 1986, this journal has consistently provided a platform for high-quality research and insights, supporting the community with its impactful publications. With an impressive ranking of #55 out of 137 in the Ophthalmology category, the journal currently holds a Q2 quartile in both ophthalmology and miscellaneous medicine as of 2023, reflecting its significant contribution to the discipline. Researchers and practitioners can access a wealth of information covering a comprehensive range of topics, bolstering both clinical practice and academic inquiry. While not an open-access publication, Seminars in Ophthalmology remains a crucial resource for advancing ophthalmic research, fostering collaboration, and disseminating valuable findings in a rapidly evolving specialty.
Breast Journal
Uniting global experts in the fight against breast disease.The Breast Journal, published by Wiley-Hindawi, is a distinguished Open Access journal dedicated to the fields of internal medicine, oncology, and surgery with a particular focus on breast health and disease. Since its inception in 1995, the journal has become an essential resource for researchers and clinicians, facilitating the dissemination of high-quality research and innovative clinical practices. With an impact factor reflecting robust scholarly influence and a ranking in the Q3 quartile for both internal medicine and oncology, as well as Q2 in surgery, it showcases significant contributions that advance knowledge and improve patient outcomes. Offering unparalleled access to its articles, The Breast Journal aims to support a global audience in exploring the multifaceted challenges and breakthroughs in breast-related health, making it a vital platform for shared learning and scientific discourse.